Understanding Your Appendiceal Cancer Through Genetic Testing
Part of Cancer, Digestive system clinical trials.
This research study uses genetic and molecular testing on archived tumor samples to better understand appendiceal cancer and predict how it may progress. The goal is to help doctors personalize treatment plans based on the specific characteristics of your cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with appendiceal adenocarcinoma (a type of cancer in the appendix)
- Tumor tissue from your surgery or biopsy is available and stored in a laboratory
- The stored tissue is of good enough quality to perform genetic testing
- Your medical records contain information about your cancer diagnosis and treatment
- You are 18 years or older
- You are willing to allow researchers to use your archived tissue samples for this study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at stored tumor samples to better understand appendiceal cancer that has spread to the lining of the abdomen (peritoneal metastases). Your tumor tissue from past procedures may help researchers learn more about the cancer and how it behaves.
This study looks at genetic (inherited) and other biological factors in people with appendix cancer and, in some cases, their biological parents. The goal is to learn what may contribute to appendix cancer and help researchers better understand risk.
This study uses a blood test called ctDNA to help tailor (personalize) neoadjuvant chemotherapy for people with colorectal or appendix cancer before surgery. The goal is to see if using ctDNA can help doctors pick the most appropriate chemotherapy plan for you.
This study uses gene testing on stored tumor tissue (and a blood sample) to help doctors recommend treatment options that may fit your tumor’s specific changes. It may also help avoid certain medicines and share your de-identified data with other researchers.
This study uses genetic testing of your tumor to find specific mutations and match you with targeted therapies, aiming to improve outcomes for advanced cancers with poor prognosis. If you have pancreatic, liver, or triple negative breast cancer and are starting treatment, this trial may help you access personalized treatment options.
This study looks at how certain genetic changes in tumor tissue might help doctors monitor how well treatment is working for colorectal or small intestinal cancer. By joining, you may help researchers find better ways to track the disease and guide future treatment.
Hear when a new Appendiceal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.